We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-0.69%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$67.5B
AUM Growth
+$10.9B
Cap. Flow
+$12.7B
Cap. Flow %
18.75%
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195

Top Sells

1
NVDA icon
NVIDIA
NVDA
+$799M
2
AAPL icon
Apple
AAPL
+$563M
3
MSFT icon
Microsoft
MSFT
+$445M
4
AMZN icon
Amazon
AMZN
+$321M
5
AVGO icon
Broadcom
AVGO
+$274M

Sector Composition

1 Technology 23.92%
2 Consumer Staples 7.59%
3 Consumer Discretionary 6.94%
4 Communication Services 6.66%
5 Industrials 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COTY icon
1826
Coty
COTY
$2.19B
$29.8K ﹤0.01%
14,825
+92
+0.6% +$247
RBBN icon
1827
Ribbon Communications
RBBN
$379M
$28.8K ﹤0.01%
13,597
-3,546
-21% -$8.49K
ALEC icon
1828
Alector
ALEC
$163M
$28.4K ﹤0.01%
13,188
-1,484
-10% -$2.98K
CDXS icon
1829
Codexis
CDXS
$196M
$27.7K ﹤0.01%
16,976
-3,238
-16% -$4.62K
CNDT icon
1830
Conduent
CNDT
$245M
$26.1K ﹤0.01%
20,423
-6,125
-23% -$9.34K
IKT icon
1831
Inhibikase Therapeutics
IKT
$316M
$26.1K ﹤0.01%
15,537
+4,491
+41% +$7.97K
QSI icon
1832
Quantum-Si Incorporated
QSI
$178M
$25.7K ﹤0.01%
33,239
-4,102
-11% -$4.25K
ACH
1833
Accendra Health
ACH
$289M
$24.9K ﹤0.01%
10,931
-2,850
-21% -$6.56K
PLX icon
1834
Protalix BioTherapeutics
PLX
$186M
$23K ﹤0.01%
10,589
-2,548
-19% -$6.32K
NNOX icon
1835
Nano X Imaging
NNOX
$72.4M
$22.9K ﹤0.01%
10,109
-1,633
-14% -$4.3K
XRX icon
1836
Xerox
XRX
$350M
$22K ﹤0.01%
17,075
-4,446
-21% -$8.79K
LDI icon
1837
loanDepot
LDI
$607M
$20.7K ﹤0.01%
14,560
-1,751
-11% -$3.6K
HUMA icon
1838
Humacyte
HUMA
$178M
$19.5K ﹤0.01%
32,125
-4,498
-12% -$4.68K
FATE icon
1839
Fate Therapeutics
FATE
$318M
$18.9K ﹤0.01%
15,764
-4,108
-21% -$5K
LPRO
1840
Open Lending Corp
LPRO
$372M
$18.3K ﹤0.01%
14,662
-3,819
-21% -$6.04K
HRTX icon
1841
Heron Therapeutics
HRTX
$90.1M
$17.8K ﹤0.01%
22,275
-5,800
-21% -$6.72K
DOUG icon
1842
Douglas Elliman
DOUG
$175M
$17.4K ﹤0.01%
10,631
-2,745
-21% -$6.36K
IVVD icon
1843
Invivyd
IVVD
$232M
$16.1K ﹤0.01%
12,396
+156
+1% +$287
JELD icon
1844
JELD-WEN Holding
JELD
$103M
$15.3K ﹤0.01%
12,326
-3,188
-21% -$6.97K
LUCD icon
1845
Lucid Diagnostics
LUCD
$194M
$15K ﹤0.01%
13,068
-3,403
-21% -$4.33K
NFE icon
1846
New Fortress Energy
NFE
$94.3M
$15K ﹤0.01%
25,453
-6,632
-21% -$7.76K
SKIN icon
1847
SkinHealth Systems
SKIN
$106M
$14.9K ﹤0.01%
16,775
-4,118
-20% -$5.05K
PNBK icon
1848
Patriot National Bancorp
PNBK
$143M
$14.6K ﹤0.01%
11,336
-1,188
-9% -$1.71K
SKYX icon
1849
SKYX Platforms
SKYX
$159M
$14.6K ﹤0.01%
13,039
-47
-0.4% -$98
KLTR icon
1850
Kaltura
KLTR
$195M
$14K ﹤0.01%
11,450
-5,045
-31% -$7.18K

Similar funds

ProShare Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 37% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.

  • ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
  • ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
  • ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
  • ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
  • ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
  • ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
  • ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.